M814-M838
Morphology Classification: Adenomas and adenocarcinomas
- M8140/0Adenoma, NOS, benign
- M8140/1Bronchial adenoma NOS, uncertain whether benign or malignant (D38.1)
- M8140/2Adenocarcinoma in situ, NOS
- M8140/3Adenocarcinoma, NOS, malignant, primary site
- M8140/6Adenocarcinoma, NOS, malignant, metastatic site
- M8141/3Scirrhous adenocarcinoma, malignant, primary site
- M8141/6Scirrhous adenocarcinoma, malignant, metastatic site
- M8142/3Linitis plastica, malignant, primary site (C16.-)
- M8142/6Linitis plastica, malignant, metastatic site
- M8143/3Superficial spreading adenocarcinoma, malignant, primary site
- M8143/6Superficial spreading adenocarcinoma, malignant, metastatic site
- M8144/3Adenocarcinoma, intestinal type, malignant, primary site (C16.-)
- M8144/6Adenocarcinoma, intestinal type, malignant, metastatic site
- M8145/3Carcinoma, diffuse type, malignant, primary site (C16.-)
- M8145/6Carcinoma, diffuse type, malignant, metastatic site
- M8146/0Monomorphic adenoma, benign
- M8147/0Basal cell adenoma, benign (D11.-)
- M8147/3Basal cell adenocarcinoma, malignant, primary site (C07, C08.-)
- M8147/6Basal cell adenocarcinoma, malignant, metastatic site
- M8148/0Glandular intraepithelial neoplasia, low grade, benign
- M8148/2Glandular intraepithelial neoplasia, high grade, in situ
- M8149/0Canalicular adenoma, benign
- M8150/0Islet cell adenoma, benign (D13.7)
- M8150/1Pancreatic endocrine tumour, NOS, uncertain whether benign or malignant
- M8150/3Pancreatic endocrine tumour, malignant, primary site (C25.-)
- M8150/6Pancreatic endocrine tumour, malignant, metastatic site
- M8151/0Insulinoma, NOS, benign (D13.7)
- M8151/3Insulinoma, malignant, primary site (C25.4)
- M8151/6Insulinoma, malignant, metastatic site
- M8152/0Glucagonoma, NOS (D13.7)
- M8152/1Glucagonoma, NOS, uncertain whether benign or malignant (D13.7)
- M8152/3Glucagonoma, malignant, primary site (C25.4)
- M8152/6Glucagonoma, malignant, metastatic site
- M8153/1Gastrinoma, NOS, uncertain whether benign or malignant
- M8153/3Gastrinoma, malignant, primary site
- M8153/6Gastrinoma, malignant, metastatic site
- M8154/3Mixed islet cell and exocrine adenocarcinoma, malignant, primary site (C25.-)
- M8154/6Mixed islet cell and exocrine adenocarcinoma, malignant, metastatic site
- M8155/1Vipoma, NOS, uncertain whether benign or malignant
- M8155/3Vipoma, malignant, primary site
- M8155/6Vipoma, malignant, metastatic site
- M8156/1Somatostatinoma, NOS, uncertain whether benign or malignant
- M8156/3Somatostatinoma, malignant, primary site
- M8156/6Somatostatinoma, malignant, metastatic site
- M8157/1Enteroglucagonoma, NOS, uncertain whether benign or malignant
- M8157/3Enteroglucagonoma, malignant, primary site
- M8157/6Enteroglucagonoma, malignant, metastatic site
- M8158/1Endocrine tumour, functioning, NOS, uncertain whether benign or malignant
- M8160/0Bile duct adenoma, benign (D13.4, D13.5)
- M8160/3Cholangiocarcinoma, malignant, primary site (C22.1)
- M8160/6Cholangiocarcinoma, malignant, metastatic site
- M8161/0Bile duct cystadenoma, benign
- M8161/3Bile duct cystadenocarcinoma, malignant, primary site (C22.1, C24.0)
- M8161/6Bile duct cystadenocarcinoma, malignant, metastatic site
- M8162/3Klatskin tumour, malignant, primary site (C24.0)
- M8162/6Klatskin tumour, malignant, metastatic site
- M8163/0Pancreatobiliary neoplasm, benign
- M8163/2Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia, in situ
- M8163/3Pancreatobiliary-type carcinoma, malignant, primary site (C24.1)
- M8163/6Pancreatobiliary-type carcinoma, malignant, metastatic site
- M8170/0Liver cell adenoma, benign (D13.4)
- M8170/3Hepatocellular carcinoma, NOS, malignant, primary site (C22.0)
- M8170/6Hepatocellular carcinoma, NOS, malignant, metastatic site
- M8171/3Hepatocellular carcinoma, fibrolamellar, malignant, primary site (C22.0)
- M8171/6Hepatocellular carcinoma, fibrolamellar, malignant, metastatic site
- M8172/3Hepatocellular carcinoma, scirrhous, malignant, primary site (C22.0)
- M8172/6Hepatocellular carcinoma, scirrhous, malignant, metastatic site
- M8173/3Hepatocellular carcinoma, spindle cell variant, malignant, primary site (C22.0)
- M8173/6Hepatocellular carcinoma, spindle cell variant, malignant, metastatic site
- M8174/3Hepatocellular carcinoma, clear cell type, malignant, primary site (C22.0)
- M8174/6Hepatocellular carcinoma, clear cell type, malignant, metastatic site
- M8175/3Hepatocellular carcinoma, pleomorphic type, malignant, primary site (C22.0)
- M8175/6Hepatocellular carcinoma, pleomorphic type, malignant, metastatic site
- M8180/3Combined hepatocellular carcinoma and cholangiocarcinoma, malignant, primary site (C22.0)
- M8180/6Combined hepatocellular carcinoma and cholangiocarcinoma, malignant, metastatic site
- M8190/0Trabecular adenoma, benign
- M8190/3Trabecular adenocarcinoma, malignant, primary site
- M8190/6Trabecular adenocarcinoma, malignant, metastatic site
- M8191/0Embryonal adenoma, benign
- M8200/0Eccrine dermal cylindroma, benign (D23.-)
- M8200/3Adenoid cystic carcinoma, malignant, primary site
- M8200/6Adenoid cystic carcinoma, malignant, metastatic site
- M8201/2Cribriform carcinoma in situ
- M8201/3Cribriform carcinoma, malignant, primary site
- M8201/6Cribriform carcinoma, malignant, metastatic site
- M8202/0Microcystic adenoma, benign (D13.6)
- M8204/0Lactating adenoma, benign
- M8210/0Adenomatous polyp, NOS, benign
- M8210/2Adenocarcinoma in situ in adenomatous polyp
- M8210/3Adenocarcinoma in adenomatous polyp, malignant, primary site
- M8211/0Tubular adenoma, NOS, benign
- M8211/3Tubular adenocarcinoma, malignant, primary site
- M8211/6Tubular adenocarcinoma, malignant, metastatic site
- M8212/0Flat adenoma, benign
- M8213/0Serrated adenoma, benign
- M8213/3Serrated adenocarcinoma, malignant, primary site
- M8213/6Serrated adenocarcinoma, malignant, metastatic site
- M8214/3Parietal cell carcinoma, malignant, primary site (C16.-)
- M8214/6Parietal cell carcinoma, malignant, metastatic site
- M8215/3Adenocarcinoma of anal glands, malignant, primary site
- M8215/6Adenocarcinoma of anal glands, malignant, metastatic site
- M8220/0Adenomatous polyposis coli, benign (D12.-)
- M8220/3Adenocarcinoma in adenomatous polyposis coli, malignant, primary site (C18.-)
- M8220/6Adenocarcinoma in adenomatous polyposis coli, malignant, metastatic site
- M8221/0Multiple adenomatous polyps, benign
- M8221/3Adenocarcinoma in multiple adenomatous polyps, malignant, primary site
- M8221/6Adenocarcinoma in multiple adenomatous polyps, malignant, metastatic site
- M8230/2Ductal carcinoma in situ, solid type
- M8230/3Solid carcinoma, NOS, malignant, primary site
- M8230/6Solid carcinoma, NOS, malignant, metastatic site
- M8231/3Carcinoma simplex, malignant, primary site
- M8231/6Carcinoma simplex, malignant, metastatic site
- M8240/1Carcinoid tumour NOS, of appendix, uncertain whether benign or malignant (D37.3)
- M8240/3Carcinoid tumour, NOS, malignant, primary site (except of appendix M8240/1)
- M8240/6Carcinoid tumour, NOS, malignant, metastatic site
- M8241/1Carcinoid tumour, argentaffin NOS, uncertain whether benign or malignant
- M8241/3Carcinoid tumour, argentaffin, malignant, primary site
- M8241/6Carcinoid tumour, argentaffin, malignant, metastatic site
- M8242/1Enterochromaffin-like cell carcinoid, NOS, uncertain whether benign or malignant
- M8242/3Enterochromaffin-like cell tumour, malignant, primary site
- M8242/6Enterochromaffin-like cell tumour, malignant, metastatic site
- M8243/3Goblet cell carcinoid, malignant, primary site (C18.1)
- M8243/6Goblet cell carcinoid, malignant, metastatic site
- M8244/3Mixed adenoneuroendocrine carcinoma, malignant, primary site
- M8244/6Mixed adenoneuroendocrine carcinoma, malignant, metastatic site
- M8245/1Tubular carcinoid, uncertain whether benign or malignant
- M8245/3Adenocarcinoid tumour, malignant, primary site
- M8245/6Adenocarcinoid tumour, malignant, metastatic site
- M8246/3Neuroendocrine carcinoma, malignant, primary site
- M8246/6Neuroendocrine carcinoma, malignant, metastatic site
- M8247/3Merkel cell carcinoma, malignant, primary site (C44.-)
- M8247/6Merkel cell carcinoma, malignant, metastatic site
- M8248/1Apudoma, uncertain whether benign or malignant
- M8249/3Neuroendocrine carcinoma, moderately differentiated, malignant, primary site
- M8249/6Neuroendocrine carcinoma, moderately differentiated, malignant, metastatic site
- M8250/1Pulmonary adenomatosis, uncertain whether benign or malignant (D38.1)
- M8250/3Bronchiolo-alveolar adenocarcinoma, malignant, primary site (C34.-)
- M8250/6Bronchiolo-alveolar adenocarcinoma, malignant, metastatic site
- M8251/0Alveolar adenoma, benign (D14.3)
- M8251/3Alveolar adenocarcinoma, malignant, primary site (C34.-)
- M8251/6Alveolar adenocarcinoma, malignant, metastatic site
- M8252/3Bronchiolo-alveolar carcinoma, non-mucinous, malignant, primary site (C34.-)
- M8252/6Bronchiolo-alveolar carcinoma, non-mucinous, malignant, metastatic site
- M8253/3Bronchiolo-alveolar carcinoma, mucinous, malignant, primary site (C34.-)
- M8253/6Bronchiolo-alveolar carcinoma, mucinous, malignant, metastatic site
- M8254/3Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous, malignant, primary site (C34.-)
- M8254/6Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous, malignant, metastatic site
- M8255/3Adenocarcinoma with mixed subtypes, malignant, primary site
- M8255/6Adenocarcinoma with mixed subtypes, malignant, metastatic site
- M8260/0Papillary adenoma, NOS, benign
- M8260/3Papillary adenocarcinoma, NOS, malignant, primary site
- M8260/6Papillary adenocarcinoma, NOS, malignant, metastatic site
- M8261/0Villous adenoma, NOS, benign
- M8261/1Villous adenoma, NOS
- M8261/2Adenocarcinoma in situ in villous adenoma
- M8261/3Adenocarcinoma in villous adenoma, malignant, primary site
- M8261/6Adenocarcinoma in villous adenoma, malignant, metastatic site
- M8262/3Villous adenocarcinoma, malignant, primary site
- M8262/6Villous adenocarcinoma, malignant, metastatic site
- M8263/0Tubulovillous adenoma, NOS, benign
- M8263/2Adenocarcinoma in situ in tubulovillous adenoma
- M8263/3Adenocarcinoma in tubulovillous adenoma, malignant, primary site
- M8263/6Adenocarcinoma in tubulovillous adenoma, malignant, metastatic site
- M8264/0Papillomatosis, glandular, benign
- M8265/3Micropapillary carcinoma, NOS, malignant, primary site (C18.-, C19.9, C20.9)
- M8265/6Micropapillary carcinoma, NOS, malignant, metastatic site
- M8270/0Chromophobe adenoma, benign (D35.2)
- M8270/3Chromophobe carcinoma, malignant, primary site (C75.1)
- M8270/6Chromophobe carcinoma, malignant, metastatic site
- M8271/0Prolactinoma, benign (D35.2)
- M8272/0Pituitary adenoma, NOS, benign
- M8272/3Pituitary carcinoma, NOS, malignant, primary site (C75.1)
- M8272/6Pituitary carcinoma, NOS, malignant, metastatic site
- M8280/0Acidophil adenoma, benign (D35.2)
- M8280/3Acidophil carcinoma, malignant, primary site (C75.1)
- M8280/6Acidophil carcinoma, malignant, metastatic site
- M8281/0Mixed acidophil-basophil adenoma, benign (D35.2)
- M8281/3Mixed acidophil-basophil carcinoma, malignant, primary site (C75.1)
- M8281/6Mixed acidophil-basophil carcinoma, malignant, metastatic site
- M8290/0Oxyphilic adenoma, benign
- M8290/3Oxyphilic adenocarcinoma, malignant, primary site
- M8290/6Oxyphilic adenocarcinoma, malignant, metastatic site
- M8300/0Basophil adenoma, benign (D35.2)
- M8300/3Basophil carcinoma, malignant, primary site (C75.1)
- M8300/6Basophil carcinoma, malignant, metastatic site
- M8310/0Clear cell adenoma, benign
- M8310/3Clear cell adenocarcinoma, NOS, malignant, primary site
- M8310/6Clear cell adenocarcinoma, NOS, malignant, metastatic site
- M8311/1Hypernephroid tumour, uncertain whether benign or malignant
- M8312/3Renal cell carcinoma, NOS, malignant, primary site (C64)
- M8312/6Renal cell carcinoma, NOS, malignant, metastatic site
- M8313/0Clear cell adenofibroma, benign
- M8313/1Clear cell adenofibroma of borderline malignancy, uncertain whether benign or malignant
- M8313/3Clear cell adenocarcinofibroma, malignant, primary site (C56)
- M8313/6Clear cell adenocarcinofibroma, malignant, metastatic site
- M8314/3Lipid-rich carcinoma, malignant, primary site (C50.-)
- M8314/6Lipid-rich carcinoma, malignant, metastatic site
- M8315/3Glycogen-rich carcinoma, malignant, primary site (C50.-)
- M8315/6Glycogen-rich carcinoma, malignant, metastatic site
- M8316/3Cyst-associated renal cell carcinoma, malignant, primary site (C64)
- M8316/6Cyst-associated renal cell carcinoma, malignant, metastatic site
- M8317/3Renal cell carcinoma, chromophobe type, malignant, primary site (C64)
- M8317/6Renal cell carcinoma, chromophobe type, malignant, metastatic site
- M8318/3Renal cell carcinoma, sarcomatoid, malignant, primary site (C64)
- M8318/6Renal cell carcinoma, sarcomatoid, malignant, metastatic site
- M8319/3Collecting duct carcinoma, malignant, primary site (C64)
- M8319/6Collecting duct carcinoma, malignant, metastatic site
- M8320/3Granular cell carcinoma, malignant, primary site
- M8320/6Granular cell carcinoma, malignant, metastatic site
- M8321/0Chief cell adenoma, benign (D35.1)
- M8322/0Water-clear cell adenoma, benign (D35.1)
- M8322/3Water-clear cell adenocarcinoma, malignant, primary site (C75.0)
- M8322/6Water-clear cell adenocarcinoma, malignant, metastatic site
- M8323/0Mixed cell adenoma, benign
- M8323/3Mixed cell adenocarcinoma, malignant, primary site
- M8323/6Mixed cell adenocarcinoma, malignant, metastatic site
- M8324/0Lipoadenoma, benign
- M8325/0Metanephric adenoma, benign
- M8330/0Follicular adenoma, benign (D34)
- M8330/1Atypical follicular adenoma, uncertain whether benign or malignant
- M8330/3Follicular adenocarcinoma, NOS, malignant, primary site (C73)
- M8330/6Follicular adenocarcinoma, NOS, malignant, metastatic site
- M8331/3Follicular adenocarcinoma, well differentiated, malignant, primary site (C73)
- M8331/6Follicular adenocarcinoma, well differentiated, malignant, metastatic site
- M8332/3Follicular adenocarcinoma, trabecular, malignant, primary site (C73)
- M8332/6Follicular adenocarcinoma, trabecular, malignant, metastatic site
- M8333/0Microfollicular adenoma, benign (D34)
- M8333/3Fetal adenocarcinoma, malignant, primary site
- M8333/6Fetal adenocarcinoma, malignant, metastatic site
- M8334/0Macrofollicular adenoma, benign (D34)
- M8335/3Follicular carcinoma, minimally invasive, malignant, primary site (C73)
- M8335/6Follicular carcinoma, minimally invasive, malignant, metastatic site
- M8336/0Hyalinizing trabecular adenoma, benign
- M8337/3Insular carcinoma, malignant, primary site (C73)
- M8337/6Insular carcinoma, malignant, metastatic site
- M8340/3Papillary carcinoma, follicular variant, malignant, primary site (C73)
- M8340/6Papillary carcinoma, follicular variant, malignant, metastatic site
- M8341/3Papillary microcarcinoma, malignant, primary site (C73)
- M8341/6Papillary microcarcinoma, malignant, metastatic site
- M8342/3Papillary carcinoma, oxyphilic cell, malignant, primary site (C73)
- M8342/6Papillary carcinoma, oxyphilic cell, malignant, metastatic site
- M8343/3Papillary carcinoma, encapsulated, malignant, primary site (C73)
- M8343/6Papillary carcinoma, encapsulated, malignant, metastatic site
- M8344/3Papillary carcinoma, columnar cell, malignant, primary site (C73)
- M8344/6Papillary carcinoma, columnar cell, malignant, metastatic site
- M8346/3Mixed medullary-follicular carcinoma, malignant, primary site (C73)
- M8346/6Mixed medullary-follicular carcinoma, malignant, metastatic site
- M8347/3Mixed medullary-papillary carcinoma, malignant, primary site (C73)
- M8347/6Mixed medullary-papillary carcinoma, malignant, metastatic site
- M8350/3Nonencapsulated sclerosing carcinoma, malignant, primary site (C73)
- M8350/6Nonencapsulated sclerosing carcinoma, malignant, metastatic site
- M8360/1Multiple endocrine adenomas, uncertain whether benign or malignant
- M8361/0Juxtaglomerular tumour, benign
- M8361/1Juxtaglomerular tumour, uncertain whether benign or malignant (D41.0)
- M8370/0Adrenal cortical adenoma, NOS, benign (D35.0)
- M8370/3Adrenal cortical carcinoma, malignant, primary site (C74.0)
- M8370/6Adrenal cortical carcinoma, malignant, metastatic site
- M8371/0Adrenal cortical adenoma, compact cell, benign (D35.0)
- M8372/0Adrenal cortical adenoma, heavily pigmented variant, benign (D35.0)
- M8373/0Adrenal cortical adenoma, clear cell, benign (D35.0)
- M8374/0Adrenal cortical adenoma, glomerulosa cell, benign (D35.0)
- M8375/0Adrenal cortical adenoma, mixed cell, benign (D35.0)
- M8380/0Endometrioid adenoma, NOS, benign (D27)
- M8380/1Endometrioid adenoma, borderline malignancy, uncertain whether benign or malignant (D39.1)
- M8380/3Endometrioid carcinoma, malignant, primary site (C56)
- M8380/6Endometrioid carcinoma, malignant, metastatic site
- M8381/0Endometrioid adenofibroma, NOS, benign (D27)
- M8381/1Endometrioid adenofibroma, borderline malignancy, uncertain whether benign or malignant (D39.1)
- M8381/3Endometrioid adenofibroma, malignant, primary site (C56)
- M8381/6Endometrioid adenofibroma, malignant, metastatic site
- M8382/3Endometrioid adenocarcinoma, secretory variant, malignant, primary site
- M8382/6Endometrioid adenocarcinoma, secretory variant, malignant, metastatic site
- M8383/3Endometrioid adenocarcinoma, ciliated cell variant, malignant, primary site
- M8383/6Endometrioid adenocarcinoma, ciliated cell variant, malignant, metastatic site
- M8384/3Adenocarcinoma, endocervical type, malignant, primary site
- M8384/6Adenocarcinoma, endocervical type, malignant, metastatic site